These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2009-017222-39 Ensayo clínico aleatorizado, doble ciego, doble enmascarado, multicéntrico para evaluar la eficacia y seguridad de 5 mg de mifepristona oral comparado con triptorelina IM administrados durante 4 meses... not-yet-due
Reported results Terminated 2016-001011-21 A prospesctive, open-label 12-weeks treatment study to determine the effect of tadalafil 5 mg on clitoral blood flow in menopausal and hipertensive women with sexual interest and arousal disorder ... 2019-02-26 due-trials
Listed as ongoing, but also has a completion date 2018-002367-26 A randomized, double-blind, three-arm, parallel-group, multicentre superiority study assessing the efficacy and safety of mifepristone (2.5 mg and 5 mg) vs. placebo for the treatment of endometriosis ... 2022-11-09 bad-data
Completed, but no date Terminated 2020-004302-63 A multi-centre, open-label, single-arm study assessing the safety and efficacy of 5 mg of mifepristone for the treatment of endometriosis in reproductive-age women during two treatment cycles of 24 we... bad-data